GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Ekso Bionics Holdings Inc (NAS:EKSO) » Definitions » Shiller PE Ratio

Ekso Bionics Holdings (Ekso Bionics Holdings) Shiller PE Ratio : (As of Jun. 08, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Ekso Bionics Holdings Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Ekso Bionics Holdings Shiller PE Ratio Historical Data

The historical data trend for Ekso Bionics Holdings's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ekso Bionics Holdings Shiller PE Ratio Chart

Ekso Bionics Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Ekso Bionics Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Ekso Bionics Holdings's Shiller PE Ratio

For the Medical Instruments & Supplies subindustry, Ekso Bionics Holdings's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ekso Bionics Holdings's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Ekso Bionics Holdings's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Ekso Bionics Holdings's Shiller PE Ratio falls into.



Ekso Bionics Holdings Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Ekso Bionics Holdings's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Ekso Bionics Holdings's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.2/131.7762*131.7762
=-0.200

Current CPI (Mar. 2024) = 131.7762.

Ekso Bionics Holdings Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 -4.052 100.560 -5.310
201409 -3.241 100.428 -4.253
201412 -18.637 99.070 -24.790
201503 -3.241 99.621 -4.287
201506 -4.515 100.684 -5.909
201509 -4.052 100.392 -5.319
201512 -7.293 99.792 -9.630
201603 -5.093 100.470 -6.680
201606 -7.061 101.688 -9.150
201609 -9.000 101.861 -11.643
201612 -5.250 101.863 -6.792
201703 -5.700 102.862 -7.302
201706 -3.300 103.349 -4.208
201709 -2.700 104.136 -3.417
201712 -2.247 104.011 -2.847
201803 -1.950 105.290 -2.441
201806 -1.950 106.317 -2.417
201809 -1.650 106.507 -2.041
201812 -1.050 105.998 -1.305
201903 -1.510 107.251 -1.855
201906 -0.650 108.070 -0.793
201909 0.040 108.329 0.049
201912 -0.600 108.420 -0.729
202003 -0.440 108.902 -0.532
202006 -1.880 108.767 -2.278
202009 -0.010 109.815 -0.012
202012 -0.460 109.897 -0.552
202103 -0.340 111.754 -0.401
202106 -0.110 114.631 -0.126
202109 -0.170 115.734 -0.194
202112 -0.230 117.630 -0.258
202203 -0.360 121.301 -0.391
202206 -0.230 125.017 -0.242
202209 -0.330 125.227 -0.347
202212 -0.240 125.222 -0.253
202303 -0.330 127.348 -0.341
202306 -0.310 128.729 -0.317
202309 -0.240 129.860 -0.244
202312 -0.220 129.419 -0.224
202403 -0.200 131.776 -0.200

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Ekso Bionics Holdings  (NAS:EKSO) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Ekso Bionics Holdings Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Ekso Bionics Holdings's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Ekso Bionics Holdings (Ekso Bionics Holdings) Business Description

Traded in Other Exchanges
Address
101 Glacier Point, Suite A, San Rafael, CA, USA, 94901
Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are EksoHealth and EksoWorks. All of the company's operations are held in the United States. The EksoHealth segment which derives majority revenue designs, engineers, manufactures and sells exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. The regions company operates in are the Americas, EMEA, and APAC.
Executives
Jerome Wong officer: Interim CFO C/O EKSO BIONICS HOLDINGS, INC., 1414 HARBOUR WAY SOUTH, SUITE 1201, RICHMOND CA 94804
Scott G. Davis officer: President & COO C/O EKSO BIONICS HOLDINGS, INC., 1414 HARBOUR WAY SOUTH, SUITE 1201, RICHMOND CA 94804
Steven Sherman director
Jason C Jones officer: VP of Product Development EKSO BIONICS HOLDINGS, INC., 1414 HARBOUR WAY SOUTH, SUITE 1201, RICHMOND CA 94804
John Glenn officer: Chief Financial Officer 7900 HOPYARD ROAD, APT 210, PLEASANTON CA 94577
Lathan Corinna director 140 KENDRICK STREET, NEEDHAM MA 02494
William R Shaw officer: See Remarks 1414 HARBOUR WAY SOUTH, SUITE 1201, C/O EKSO BIONICS HOLDINGS, INC., RICHMOND CA 94804
Rhonda A. Wallen director C/O EKSO BIONICS HOLDINGS, INC., 1414 HARBOUR WAY SOUTH, SUITE 1201, RICHMOND CA 94804
Mary Ann Cloyd director 184 LIBERTY CORNER ROAD, SUITE 302, WARREN NJ 07059
Combest Development (hong Kong) Ltd 10 percent owner ROOM 2210, CC WU BUILDING 302, HENNESSY ROAD, WAN CHAI, HONG KONG K3 999077
Jack Peurach director, officer: Chief Executive Officer 1414 HARBOUR WAY SOUTH, SUITE 1201, RICHMOND CA 94804
Thomas A Schreck director 10240 BUBB RD, CUPERTINO CA 95014
Puissance Capital Management Lp 10 percent owner 950 THIRD AVENUE, 25TH FLOOR, NEW YORK NY 10022
Christian Babini officer: VP of Sales, Americas C/O EKSO BIONICS HOLDINGS, INC., 1414 HARBOUR WAY SOUTH, SUITE 1, RICHMOND CA 94804
Puissance Cross-border Opportunities Ii Llc 10 percent owner C/O PUISSANCE CAPITAL FUND (GP) LLC, 950 THIRD AVENUE, NEW YORK NY 10022